Skip to main content
Top
Published in: Intensive Care Medicine 2/2022

01-02-2022 | Diuretics | Original

Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation After Resuscitation-2 (RADAR-2) randomised clinical trial

Authors: Jonathan A. Silversides, Ross McMullan, Lydia M. Emerson, Ian Bradbury, Jonathan Bannard-Smith, Tamas Szakmany, John Trinder, Anthony J. Rostron, Paul Johnston, Andrew J. Ferguson, Andrew J. Boyle, Bronagh Blackwood, John C. Marshall, Daniel F. McAuley

Published in: Intensive Care Medicine | Issue 2/2022

Login to get access

Abstract

Purpose

Fluid overload is common in critical illness and is associated with mortality. This study investigated the feasibility of a randomised trial comparing conservative fluid administration and deresuscitation (active removal of accumulated fluid using diuretics or ultrafiltration) with usual care in critical illness.

Methods

Open-label, parallel-group, allocation-concealed randomised clinical feasibility trial. Mechanically ventilated adult patients expected to require critical care beyond the next calendar day were enrolled between 24 and 48 h following admission to the intensive care unit (ICU). Patients were randomised to either a 2-stage fluid strategy comprising conservative fluid administration and, if fluid overload was present, active deresuscitation, or usual care. The primary endpoint was fluid balance in the 24 h up to the start of study day 3. Secondary endpoints included cumulative fluid balance, mortality, and duration of mechanical ventilation.

Results

One hundred and eighty patients were randomised. After withdrawal of 1 patient, 89 patients assigned to the intervention were compared with 90 patients assigned to the usual care group. The mean plus standard deviation (SD) 24-h fluid balance up to study day 3 was lower in the intervention group (− 840 ± 1746 mL) than the usual care group (+ 130 ± 1401 mL; P < 0.01). Cumulative fluid balance was lower in the intervention group at days 3 and 5. Overall, clinical outcomes did not differ significantly between the two groups, although the point estimate for 30-day mortality favoured the usual care group [intervention arm: 19 of 90 (21.6%) versus usual care: 14 of 89 (15.6%), P = 0.32]. Baseline imbalances between groups and lack of statistical power limit interpretation of clinical outcomes.

Conclusions

A strategy of conservative fluid administration and active deresuscitation is feasible, reduces fluid balance compared with usual care, and may cause benefit or harm. In view of wide variations in contemporary clinical practice, large, adequately powered trials investigating the clinical effectiveness of conservative fluid strategies in critically ill patients are warranted.
Appendix
Available only for authorised users
Literature
2.
go back to reference Moraes RB, Friedman G, Viana MV et al (2013) Aldosterone secretion in patients with septic shock: a prospective study. Arq Bras Endocrinol Metabol 57:636–641CrossRefPubMed Moraes RB, Friedman G, Viana MV et al (2013) Aldosterone secretion in patients with septic shock: a prospective study. Arq Bras Endocrinol Metabol 57:636–641CrossRefPubMed
5.
go back to reference Wagener G, Bakker J (2015) Vasopressin in cirrhosis and sepsis: physiology and clinical implications. Minerva Anestesiol 81:1377–1383PubMed Wagener G, Bakker J (2015) Vasopressin in cirrhosis and sepsis: physiology and clinical implications. Minerva Anestesiol 81:1377–1383PubMed
15.
16.
18.
go back to reference Silversides J, Marshall JC, Ferguson A et al (2018) Role of Active Deresuscitation After Resuscitation-2 (RADAR-2)—a pilot randomised controlled trial of conservative fluid administration and deresuscitation in critical illness: study protocol. Crit Care Horizons 1–7 Silversides J, Marshall JC, Ferguson A et al (2018) Role of Active Deresuscitation After Resuscitation-2 (RADAR-2)—a pilot randomised controlled trial of conservative fluid administration and deresuscitation in critical illness: study protocol. Crit Care Horizons 1–7
23.
go back to reference Weiss, (2004) The impact of event scale – revised. In: Wilson JP, Keane TM (eds) Assessing psychological trauma and PTSD. The Guilford Press, New York, pp 168–189 Weiss, (2004) The impact of event scale – revised. In: Wilson JP, Keane TM (eds) Assessing psychological trauma and PTSD. The Guilford Press, New York, pp 168–189
29.
go back to reference Bellomo R, Prowle JR, Echeverri JE (2010) Diuretic therapy in fluid-overloaded and heart failure patients. In: Ronco C, Costanzo MR, Bellomo R, Maisel AS (eds) Fluid overload. KARGER, Basel, pp 153–163CrossRef Bellomo R, Prowle JR, Echeverri JE (2010) Diuretic therapy in fluid-overloaded and heart failure patients. In: Ronco C, Costanzo MR, Bellomo R, Maisel AS (eds) Fluid overload. KARGER, Basel, pp 153–163CrossRef
Metadata
Title
Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation After Resuscitation-2 (RADAR-2) randomised clinical trial
Authors
Jonathan A. Silversides
Ross McMullan
Lydia M. Emerson
Ian Bradbury
Jonathan Bannard-Smith
Tamas Szakmany
John Trinder
Anthony J. Rostron
Paul Johnston
Andrew J. Ferguson
Andrew J. Boyle
Bronagh Blackwood
John C. Marshall
Daniel F. McAuley
Publication date
01-02-2022
Publisher
Springer Berlin Heidelberg
Keywords
Diuretics
Care
Published in
Intensive Care Medicine / Issue 2/2022
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-021-06596-8

Other articles of this Issue 2/2022

Intensive Care Medicine 2/2022 Go to the issue